Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Large Dose DPI

Disposable DPI for high dose drug delivery.

Page
Read more

OWN it! Training and Development Needs FY24

Take an active role in your personal development. Follow the new process to identify, plan and own your training and development needs for FY24.

Page
Read more

API

ËÄÉ«AV inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more